MDA-MB-231 NAT1-/- 2-19 (Q108820874)

From Wikidata

Jump to navigation Jump to search

cell line

MDA-MB-231 2
CRISPR 2-19

Language	Label	Description	Also known as
English	MDA-MB-231 NAT1-/- 2-19	cell line	MDA-MB-231 2 CRISPR 2-19

Statements

1 reference

Cellosaurus release 44

23 January 2023

cancer cell line

1 reference

Cellosaurus release 44

23 January 2023

parent cell line

MDA-MB-231 NAT1 scrambled

1 reference

Cellosaurus release 44

23 January 2023

described by source

Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity

1 reference

Cellosaurus release 44

23 January 2023

CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism

1 reference

Cellosaurus release 44

23 January 2023

established from medical condition

breast adenocarcinoma

1 reference

Cellosaurus release 44

23 January 2023

derived from organism type

1 reference

Cellosaurus release 44

23 January 2023

Identifiers

1 reference

Cellosaurus release 44

23 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q108820874&oldid=1861988916"